Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 25470694

First-line crizotinib versus chemotherapy in ALK-positive lung cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2014 Dec 4
First author
Solomon BJ

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2014 Dec 4;371(23):2227-8. doi: 10.1056/NEJMe1412624.
    note
    Source null
    related pmid
    25470699
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2015 Feb;12(2):66. doi: 10.1038/nrclinonc.2014.235.
    note
    Source null
    related pmid
    25560531
    relationship
    Comment in
  3. citation
    N Engl J Med. 2015 Feb 19;372(8):782. doi: 10.1056/NEJMc1415973.
    note
    Source null
    related pmid
    25693021
    relationship
    Comment in
  4. citation
    N Engl J Med. 2015 Feb 19;372(8):781. doi: 10.1056/NEJMc1415973.
    note
    Source null
    related pmid
    25693022
    relationship
    Comment in
  5. citation
    N Engl J Med. 2015 Feb 19;372(8):781-2. doi: 10.1056/NEJMc1415973.
    note
    Source null
    related pmid
    25693023
    relationship
    Comment in
  6. citation
    N Engl J Med. 2015 Oct 15;373(16):1582. doi: 10.1056/NEJMx150034.
    note
    Source null
    related pmid
    26466011
    relationship
    Erratum in

Authors and identifiers

  1. name
    Solomon BJ
    type
    Author
  2. name
    Mok T
    type
    Author
  3. name
    Kim DW
    type
    Author
  4. name
    Wu YL
    type
    Author
  5. name
    Nakagawa K
    type
    Author
  6. name
    Mekhail T
    type
    Author
  7. name
    Felip E
    type
    Author
  8. name
    Cappuzzo F
    type
    Author
  9. name
    Paolini J
    type
    Author
  10. name
    Usari T
    type
    Author
  11. name
    Iyer S
    type
    Author
  12. name
    Reisman A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Solomon BJ
    type
    Author
  2. name
    Mok T
    type
    Author
  3. name
    Kim DW
    type
    Author
  4. name
    Wu YL
    type
    Author
  5. name
    Nakagawa K
    type
    Author
  6. name
    Mekhail T
    type
    Author
  7. name
    Felip E
    type
    Author
  8. name
    Cappuzzo F
    type
    Author
  9. name
    Paolini J
    type
    Author
  10. name
    Usari T
    type
    Author
  11. name
    Iyer S
    type
    Author
  12. name
    Reisman A
    type
    Author
bibliography ids
  1. nci-bib-53f144ed9d2b6c889b5c1043
book metadata
content sha256
182437491c0e1cf713d8d070d62deb132e838dbb2fdeaa66aaddb562a60620a9
document type
citation
dois
  1. 10.1056/NEJMoa1408440
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:25470694
immutable id
pubmed:25470694@182437491c0e1cf713d8d070d62deb132e838dbb2fdeaa66aaddb562a60620a9
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
23
name
The New England journal of medicine
nlm unique id
0255562
pages
2167-77
volume
371
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2014 Dec 4;371(23):2227-8. doi: 10.1056/NEJMe1412624.
    note
    Source null
    related pmid
    25470699
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2015 Feb;12(2):66. doi: 10.1038/nrclinonc.2014.235.
    note
    Source null
    related pmid
    25560531
    relationship
    Comment in
  3. citation
    N Engl J Med. 2015 Feb 19;372(8):782. doi: 10.1056/NEJMc1415973.
    note
    Source null
    related pmid
    25693021
    relationship
    Comment in
  4. citation
    N Engl J Med. 2015 Feb 19;372(8):781. doi: 10.1056/NEJMc1415973.
    note
    Source null
    related pmid
    25693022
    relationship
    Comment in
  5. citation
    N Engl J Med. 2015 Feb 19;372(8):781-2. doi: 10.1056/NEJMc1415973.
    note
    Source null
    related pmid
    25693023
    relationship
    Comment in
  6. citation
    N Engl J Med. 2015 Oct 15;373(16):1582. doi: 10.1056/NEJMx150034.
    note
    Source null
    related pmid
    26466011
    relationship
    Erratum in
outcomes validated
false
pmid
25470694
provenance
batch id
863b068fe5a07222af6a
provider
NCBI PubMed ESummary
record sha256
05b3597e2e469902d731ee3108afb626c47f8f8132ff483d1f6e923c8ea3fa15
response sha256
80b1cc99e93fcfceb3e1b12ea433c615b032a2db13a615db7a6e9382c17c5034
retrieved at
2026-09-09T23:47:07.648963+00:00
publication date
display
2014 Dec 4
precision
day
year
2014
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/25470694/
title
First-line crizotinib versus chemotherapy in ALK-positive lung cancer.

Preserved source evidence · Not medical advice